VOYA Investment Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Buy
32,111
+2,295
+8% +$82.6K ﹤0.01% 1484
2026
Q1
$1.05M Buy
29,816
+2,022
+7% +$82.3K ﹤0.01% 1435
2025
Q4
$1.13M Buy
27,794
+442
+2% +$19.2K ﹤0.01% 1441
2025
Q3
$1.29M Sell
27,352
-4,439
-14% -$230K ﹤0.01% 1394
2025
Q2
$1.66M Sell
31,791
-213
-0.7% -$11.7K ﹤0.01% 1375
2025
Q1
$1.93M Buy
32,004
+10,058
+46% +$648K ﹤0.01% 1324
2024
Q4
$1.5M Sell
21,946
-489
-2% -$34.1K ﹤0.01% 1413
2024
Q3
$1.61M Sell
22,435
-177
-0.8% -$12.5K ﹤0.01% 1412
2024
Q2
$1.57M Buy
22,612
+160
+0.7% +$11.7K ﹤0.01% 1401
2024
Q1
$1.8M Sell
22,452
-478,065
-96% -$42.6M ﹤0.01% 1382
2023
Q4
$54.8M Buy
500,517
+14,694
+3% +$1.52M 0.06% 318
2023
Q3
$49M Buy
485,823
+71,535
+17% +$8.22M 0.05% 328
2023
Q2
$56.3M Buy
414,288
+72,553
+21% +$8.86M 0.06% 309
2023
Q1
$35.5M Sell
341,735
-1,316
-0.4% -$127K 0.04% 401
2022
Q4
$30.4M Buy
343,051
+54,456
+19% +$4.52M 0.04% 441
2022
Q3
$23.1M Sell
288,595
-5,009
-2% -$473K 0.03% 459
2022
Q2
$28.1M Sell
293,604
-9,694
-3% -$1.16M 0.07% 243
2022
Q1
$45.1M Sell
303,298
-8,328
-3% -$1.16M 0.09% 194
2021
Q4
$44.2M Buy
311,626
+288,840
+1,268% +$40.9M 0.08% 212
2021
Q3
$2.98M Buy
22,786
+465
+2% +$60.8K 0.01% 1008
2021
Q2
$3.07M Sell
22,321
-943
-4% -$129K 0.01% 1024
2021
Q1
$3.04M Sell
23,264
-58
-0.2% -$6.98K 0.01% 1005
2020
Q4
$2.61M Buy
23,322
+8,684
+59% +$822K 0.01% 1027
2020
Q3
$1.15M Sell
14,638
-195
-1% -$15.9K ﹤0.01% 1223
2020
Q2
$1.07M Sell
14,833
-221,718
-94% -$15.4M ﹤0.01% 1240
2020
Q1
$13.5M Sell
236,551
-23,874
-9% -$2.2M 0.04% 393
2019
Q4
$29.1M Buy
260,425
+100,274
+63% +$10.7M 0.06% 281
2019
Q3
$15.4M Sell
160,151
-14,155
-8% -$1.33M 0.03% 466
2019
Q2
$14.9M Buy
174,306
+29,125
+20% +$2.39M 0.03% 482
2019
Q1
$12.1M Buy
145,181
+128,310
+761% +$9.32M 0.03% 527
2018
Q4
$1.08M Buy
16,871
+104
+0.6% +$7.12K ﹤0.01% 1275
2018
Q3
$1.33M Buy
16,767
+5,683
+51% +$440K ﹤0.01% 1259
2018
Q2
$811K Sell
11,084
-1,205
-10% -$81.9K ﹤0.01% 1503
2018
Q1
$778K Sell
12,289
-630
-5% -$37.6K ﹤0.01% 1528
2017
Q4
$658K Hold
12,919
﹤0.01% 1674
2017
Q3
$678K Hold
12,919
﹤0.01% 1661
2017
Q2
$658K Buy
12,919
+928
+8% +$45.9K ﹤0.01% 1658
2017
Q1
$533K Hold
11,991
﹤0.01% 1680
2016
Q4
$530K Sell
11,991
-527
-4% -$22.4K ﹤0.01% 1703
2016
Q3
$501 Hold
12,518
﹤0.01% 1725
2016
Q2
$597K Hold
12,518
﹤0.01% 1592
2016
Q1
$525K Hold
12,518
﹤0.01% 1659
2015
Q4
$551K Hold
12,518
﹤0.01% 1648
2015
Q3
$598K Sell
12,518
-2,996
-19% -$164K ﹤0.01% 1597
2015
Q2
$904K Sell
15,514
-513
-3% -$27.7K ﹤0.01% 1511
2015
Q1
$809K Sell
16,027
-16,066
-50% -$787K ﹤0.01% 1596
2014
Q4
$1.44M Sell
32,093
-1,574
-5% -$66K ﹤0.01% 1227
2014
Q3
$1.24M Hold
33,667
﹤0.01% 1306
2014
Q2
$1.49M Hold
33,667
﹤0.01% 1251
2014
Q1
$1.46M Hold
33,667
﹤0.01% 1249
2013
Q4
$1.43M Hold
33,667
﹤0.01% 1244
2013
Q3
$1.14M Hold
33,667
﹤0.01% 1344
2013
Q2
$1.05M Buy
+33,667
New +$1.09M ﹤0.01% 1357

Other funds holding CNMD

VOYA Investment Management's CNMD Position: Q2 2026 in Review

VOYA Investment Management increased its CONMED (CNMD) stake by 7.7% in Q2 2026, buying an estimated $82.6K and bringing the position to 32,111 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1484.

VOYA Investment Management first reported a position in CNMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $56.3M in Q2 2023. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • VOYA Investment Management held 32,111 shares of CONMED worth $1.05M as of Q2 2026.
  • VOYA Investment Management bought 2,295 CONMED shares in Q2 2026, an estimated $82.6K.
  • CONMED made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1484 holding.
  • VOYA Investment Management first reported a position in CONMED in Q2 2013 and has held it in 53 quarters since.
  • VOYA Investment Management's CONMED position peaked at $56.3M in Q2 2023.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.